Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Gains from Sales and Divestitures (2019 - 2025)

Innovex International (INVX) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $224541.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gains from Sales and Divestitures fell 10.25% year-over-year to $224541.0, compared with a TTM value of $224541.0 through Dec 2024, down 10.25%, and an annual FY2024 reading of $224541.0, down 10.25% over the prior year.
  • Gains from Sales and Divestitures was $224541.0 for Q4 2024 at Innovex International, down from $250176.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $265840.0 in Q4 2021 and bottomed at $172501.0 in Q4 2020.
  • Average Gains from Sales and Divestitures over 4 years is $228264.5, with a median of $237358.5 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures dropped 20.94% in 2020, then soared 54.11% in 2021.
  • Year by year, Gains from Sales and Divestitures stood at $172501.0 in 2020, then skyrocketed by 54.11% to $265840.0 in 2021, then decreased by 5.89% to $250176.0 in 2023, then fell by 10.25% to $224541.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for INVX at $224541.0 in Q4 2024, $250176.0 in Q4 2023, and $265840.0 in Q4 2021.